Semaglutide: A Breakthrough for Women with Heart Failure
Semaglutide, originally developed to treat type 2 diabetes and obesity, has shown significant improvements in symptoms for both men and women with a common, yet previously hard-to-treat type of heart failure. Presented by Dr. Subodh Verma at the American Diabetes Association’s 2024 Scientific Sessions and detailed in the Journal of the American College of Cardiology,…